It is not possible to generalize whether a positive anti-PL-7 antibody is serious or not. It usually indicates that the patient may have anti-synthetase syndrome, polymyositis, dermatomyositis, etc. Whether it is serious or not varies according to the patient’s specific type of disease, condition, and personal factors.
Anti PL-7 antibody is threonyl tRNA synthetase, which is one of the antibodies for myositis. Positive antibody usually indicates that the patient may have anti-synthetase syndrome, polymyositis, dermatomyositis, etc. Polymyositis and dermatomyositis, with standardized and timely treatment, usually have a better prognosis and do not affect the patient’s life expectancy.
It should be noted that polymyositis and dermatomyositis are more serious when combined with malignant tumors or complications such as pulmonary fibrosis and heart failure; the prognosis of anti-synthetase syndrome is related to comorbidities. Therefore, the severity of anti-PL-7 antibody positivity varies greatly depending on the type of disease, the condition of the patient, and personal factors.
Positive anti-PL-7 antibodies may also be caused by other factors, and it is recommended that patients with positive anti-PL-7 antibodies go to the Department of Rheumatology and Immunology of a regular hospital for relevant consultation.